10:25am ET
Investing
Top 10 Earnings Coming This Week
24/7 Wall St. has put together a preview of Disney, Petrobras and some of the other major companies reporting their quarterly results this week.
Companies
/Healthcare
Astrazeneca plc
$166.14
▲ $3.25 (+2.00%) today
Markets closed · 6:40am ET
AZN Coverage
Page 87:45am ET
Health and Healthcare
Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.
10:40am ET
Health and Healthcare
Top 5 Jefferies Big Pharma Stock Picks for Q4
A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good sense for long-term growth and income portfolios.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More
The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and Yum Brands.
8:25am ET
Investing
Top Jefferies Stock Picks to Buy Now Also Pay Good Dividends
One of the best things for investors to do is look for solid growth potential combined with fair valuations. Sprinkle in dividends and you have a recipe for total return success.
10:25am ET
Health and Healthcare
Jefferies Issues Top Pharma and Biohealth Stocks to Buy
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More
The top analyst upgrades, downgrades and initiations seen on Monday morning include Colgate-Palmolive, Gilead Sciences, Navistar, Occidental Petroleum, Pandora Media and Wal-Mart.
12:50pm ET
Health and Healthcare
Why AstraZeneca Could Gain Another 15% Despite Market Headwinds
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
Chris Lange 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More
The top analyst upgrades, downgrades and initiations seen on Monday morning include Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square and T-Mobile.
10:05am ET
Investing
Top 6 Companies That Destroyed Shareholders Last Week
The broad markets are continuing to hit all-time highs as the market is shifting gears out of the earnings season. Despite all the positive sentiment in the market, quite a few companies…
12:45pm ET
Health and Healthcare
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Accenture, Cognizant Tech, Fitbit, Oracle, Seagate, Vodafone and Many More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Accenture, Cognizant Technology Solutions, Fitbit, Oracle, Seagate Technology and Vodafone.
12:10pm ET
Investing
10 Stocks to Win or Lose From Brexit Vote Outcome
Perhaps the move for a rapid exit by Britain from the European Union (or Brexit) may have been interrupted due to a political murder of M.P. Jo Cox on Thursday. As this…
10:20am ET
Health and Healthcare
8 Stocks on the Move After ASCO Cancer Abstracts
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these…
9:45am ET
Health and Healthcare
4 Major FDA Decisions Expected by June
Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.